DISITAMAB VEDOTIN: 56 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
56
Total FAERS Reports
2 (3.6%)
Deaths Reported
33
Hospitalizations
56
As Primary/Secondary Suspect
5
Life-Threatening
2
Disabilities
First Report: 20190622 · Latest Report: 20250811
What Are the Most Common DISITAMAB VEDOTIN Side Effects?
#1 Most Reported
Myelosuppression
12 reports (21.4%)
#2 Most Reported
Off label use
8 reports (14.3%)
#3 Most Reported
White blood cell count decreased
7 reports (12.5%)
All DISITAMAB VEDOTIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 12 | 21.4% | 0 | 9 |
| Off label use | 8 | 14.3% | 0 | 3 |
| White blood cell count decreased | 7 | 12.5% | 0 | 4 |
| Nausea | 5 | 8.9% | 0 | 1 |
Who Reports DISITAMAB VEDOTIN Side Effects? Age & Gender Data
Gender: 78.3% female, 21.7% male. Average age: 62.4 years. Most reports from: CN. View detailed demographics →
Is DISITAMAB VEDOTIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2019 | 1 | 0 | 0 |
| 2022 | 4 | 1 | 3 |
| 2023 | 3 | 0 | 1 |
| 2024 | 22 | 0 | 18 |
| 2025 | 10 | 1 | 7 |
What Is DISITAMAB VEDOTIN Used For?
| Indication | Reports |
|---|---|
| Bladder cancer | 10 |
| Gastric cancer | 7 |
| Breast cancer | 5 |
Official FDA Label for DISITAMAB VEDOTIN
Official prescribing information from the FDA-approved drug label.